Back to top
more

Verano Holdings Corp. (VRNOF)

(Delayed Data from OTC)

$1.13 USD

1.13
94,857

-0.03 (-2.25%)

Updated Sep 17, 2025 11:54 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (87 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sundeep Ganoria headshot

Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?

by Sundeep Ganoria

Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 0.00% and -3.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Envista (NVST) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Envista (NVST) delivered earnings and revenue surprises of +8.33% and +6.34%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 40% and 2.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates

by Zacks Equity Research

LeMaitre (LMAT) delivered earnings and revenue surprises of -4% and 3.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 42.86% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Evolus (EOLS) Moves 5.5% Higher: Will This Strength Last?

by Zacks Equity Research

Evolus (EOLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of -300% and 4.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

VRNOF Stock Likely to Gain From Its Newly Opened Dispensary in Phoenix

by Zacks Equity Research

Verano is set to open a new Zen Leaf Arcadia in Phoenix, AZ, today. Zen Leaf Arcadia is located at 2710 E Indian School Road, Phoenix. It will be open daily from 8 a.m. to 10 p.m. local time.

Zacks Equity Research

Verano Expands U.S. Cannabis Footprint With New Buyouts

by Zacks Equity Research

This deal helps VRNOF foray into the Virginia market ahead of the Adult Use Program launch and will deepen the company's footprint in Arizona cannabis market.

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 0% and 0.82%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Insulet (PODD) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Analysts Estimate Verano Holdings Corp. (VRNOF) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 87.50% and 2.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Verano Holdings Corp. (VRNOF) Q1 Earnings Expected to Decline

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of -40% and 1.70%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Green Thumb Industries Inc. (GTBIF) Misses Q4 Earnings Estimates

by Zacks Equity Research

Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -80% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Medtronic (MDT) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Medtronic (MDT) delivered earnings and revenue surprises of 3.17% and 1.73%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?

Neena Mishra headshot

Cannabis ETFs: What's Behind the Latest Surge

by Neena Mishra

While marijuana ETFs have seen a recent surge, investors should be aware of the potential risks

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Surges 6.5%: Is This an Indication of Further Gains?

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 0% and 0.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Verano Holdings Corp. (VRNOF) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of -100% and 1.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Haemonetics (HAE) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Haemonetics (HAE) delivered earnings and revenue surprises of 38.16% and 4.50%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Neogen (NEOG) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Neogen (NEOG) delivered earnings and revenue surprises of 40% and 6.38%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?